MARC Record from marc_columbia

LEADER: 02169cam a2200409Ii 4500
001 10753677
005 20140617114041.0
008 140407s2014 dcu b 000 0 eng d
020 $a0309296625
020 $a9780309296625
035 $a(OCoLC)ocn875999370
035 $a(NNC)10753677
040 $aYDXCP$beng$erda$cYDXCP$dAZS
043 $an-us---
090 $aQH443$b.I57 2014
110 2 $aInstitute of Medicine (U.S.).$bCommittee on the Independent Review and Assessment of the Activities of the NIH Recombinant DNA Advisory Committee,$eissuing body.
245 10 $aOversight and review of clinical gene transfer protocols :$bassessing the role of the recombinant DNA advisory committee /$cCommittee on the Independent Review and Assessment of the Activities of the NIH Recombinant DNA Advisory Committee, Board on Health Sciences Policy ; Rebecca N. Lenzi, Bruce M. Altevogt, Lawrence O. Gostin, editors, Institute of Medicine of the National Academies.
264 1 $aWashington, D.C. :$bNational Academies Press,$c[2014]
300 $axviii, 116 pages ;$c23 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references.
530 $aAlso issued online.
610 20 $aNational Institutes of Health (U.S.).$bRecombinant DNA Advisory Committee.
650 0 $aGenetics$xResearch$xMoral and ethical aspects$zUnited States.
650 0 $aGenetics$xResearch$xHealth aspects$zUnited States.
650 0 $aRecombinant DNA$xResearch$xMoral and ethical aspects$zUnited States.
650 0 $aRecombinant DNA$xResearch$xHealth aspects$zUnited States.
650 0 $aGenetic transformation$xResearch$xMoral and ethical aspects$zUnited States.
650 0 $aGenetic transformation$xResearch$xHealth aspects$zUnited States.
650 0 $aInstitutional review boards (Medicine)$zUnited States$xEvaluation.
700 1 $aLenzi, Rebecca N.,$eeditor.
700 1 $aAltevogt, Bruce M.,$eeditor.
700 1 $aGostin, Lawrence O.$q(Lawrence Ogalthorpe),$eeditor.
856 41 $uhttp://www.nap.edu/catalog.php?record_id=18577
852 00 $boff,sci$hQH443$i.I57 2014g